Session Details
[S02]Frontier researches in medicinal chemistry contribute to the field of pharmacy
Sat. Mar 27, 2021 9:30 AM - 11:30 AM JST
Sat. Mar 27, 2021 12:30 AM - 2:30 AM UTC
Sat. Mar 27, 2021 12:30 AM - 2:30 AM UTC
[Room D] Oral Presentation D Online
Organizer: Shirai Takahiro (Grad. Sch. Biomed. Health Sci., Hiroshima Univ.)
The objective of this symposium is to discuss on the frontier researches in medicinal chemistry. Tremendous effort of human kind brought great progress for medicinal and pharmaceutical field, innovative treatment methods toward various kinds of disease are being developed every day. However, there are still many diseases that have no therapeutic approach even today. Against this background, it is important to share the advances and problems on medicinal and pharmaceutical fields with many researchers. Therefore, on this symposium, we have time to discuss on frontier researches by five researchers working on the development of methods for synthesizing bioactive compounds using own research methods. We would like to make it a place to share what kind of problems exist in the pharmaceutical field and what kind of viewpoints and directions symposiasts are promoting their research. We hope you can attend our symposium.
趣旨説明:白井 孝宏(広島大院医系科学)
[S02-1]Engineered biosynthesis of microbial medicinally active compounds
○Takayoshi Awakawa1 (1. Univ. of Tokyo, Grad. Sch. of Pharm. Sci.)
[S02-2]A strategy for “point mutation” of natural products: modular expeditious synthesis of middle-sized molecules and lead generation
○Hiroki Oguri1 (1. Graduate School of Science, The University of Tokyo)
[S02-3]Bridge between total synthesis of bioactive natural products and development of drug leads
○Satoshi Ichikawa1 (1. Faculty of Pharmaceutical Science, Hokkaido University)
[S02-4]Development of Artificial Catalysts that Photooxygenate Pathogenic Amyloid
○Youhei Sohma1 (1. Univ. of Tokyo, Grad. Sch. of Pharm. Sci.)
[S02-5]Improvement in aqueous solubility of bioactive molecules by decreasing intermolecular interaction
○Minoru Ishikawa1 (1. Graduate School of Life Sciences. Tohoku University)
